Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 3
2019 2
2020 4
2021 3
2022 2
2023 1
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Gaiteiro C, Soares J, Relvas-Santos M, Peixoto A, Ferreira D, Paulo P, Brandão A, Fernandes E, Azevedo R, Palmeira C, Freitas R, Miranda A, Osório H, Prieto J, Lima L, Silva AMN, Santos LL, Ferreira JA. Gaiteiro C, et al. Among authors: ferreira d. Theranostics. 2022 Mar 28;12(7):3150-3177. doi: 10.7150/thno.67409. eCollection 2022. Theranostics. 2022. PMID: 35547758 Free PMC article.
Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy.
Freitas R, Ferreira E, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Santos B, Gonçalves M, Quintas S, Peixoto A, Palmeira C, Silva AMN, Santos LL, Oliveira MJ, Sarmento B, Ferreira JA. Freitas R, et al. Among authors: ferreira d. ACS Nano. 2024 Apr 9;18(14):10088-10103. doi: 10.1021/acsnano.3c12487. Epub 2024 Mar 27. ACS Nano. 2024. PMID: 38535625
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy.
Freitas R, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Ferreira E, Gaiteiro C, Soares J, Cotton S, Gonçalves M, Eiras M, Santos B, Palmeira C, Correia MP, Oliveira MJ, Sarmento B, Peixoto A, Santos LL, Silva AMN, Ferreira JA. Freitas R, et al. Among authors: ferreira d. J Control Release. 2024 Mar;367:540-556. doi: 10.1016/j.jconrel.2024.01.065. Epub 2024 Feb 3. J Control Release. 2024. PMID: 38301927
Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer.
Soares J, Eiras M, Ferreira D, Santos DAR, Relvas-Santos M, Santos B, Gonçalves M, Ferreira E, Vieira R, Afonso LP, Santos LL, Dinis-Ribeiro M, Lima L, Ferreira JA. Soares J, et al. Among authors: ferreira d. Int J Mol Sci. 2024 Mar 27;25(7):3722. doi: 10.3390/ijms25073722. Int J Mol Sci. 2024. PMID: 38612533 Free PMC article.
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.
Ferreira E, Ferreira D, Relvas-Santos M, Freitas R, Soares J, Azevedo R, Afonso LP, Lima L, Santos B, Gonçalves M, Silva AMN, Santos LL, Peixoto A, Ferreira JA. Ferreira E, et al. Among authors: ferreira d. Int J Mol Sci. 2024 Mar 19;25(6):3462. doi: 10.3390/ijms25063462. Int J Mol Sci. 2024. PMID: 38542435 Free PMC article.
XPERT® breast cancer STRAT4 as an alternative method of identifying breast cancer phenotype in Cape Verde (preliminary results).
Borges PCC, Spencer HB, Barbosa C, Costa V, Furtado A, Leal MC, Lopes C, Ferreira D, Carvalho AL, Dos-Santos-Silva I, Santos LL. Borges PCC, et al. Among authors: ferreira d. Ecancermedicalscience. 2023 Apr 11;17:1530. doi: 10.3332/ecancer.2023.1530. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37138965 Free PMC article.
19 results